160 participants
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-24
- Start Date:
- 2026-08-15
- Completion:
- 2028-09-15
Conditions
- Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
- Metastatic Non-Small Cell Lung Cancer (NSCLC)
Interventions
- DRUG
No Results Yet